Naei et al.,180 in HNSCC, mapped macrophage–tumour cell barriers and immune aggregates with PhenoCycler, distinguishing responders from non‐responders to anti‐PD‐1 therapy. This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.